Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Generation Bio (GBIO) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to $8.3 million.

  • Generation Bio's Operating Expenses fell 6736.38% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.1 million, marking a year-over-year decrease of 5162.2%. This contributed to the annual value of $162.3 million for FY2024, which is 1233.15% up from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Operating Expenses is $8.3 million, which was down 6736.38% from $23.7 million recorded in Q2 2025.
  • In the past 5 years, Generation Bio's Operating Expenses registered a high of $81.7 million during Q1 2024, and its lowest value of $8.3 million during Q3 2025.
  • For the 4-year period, Generation Bio's Operating Expenses averaged around $33.6 million, with its median value being $33.1 million (2022).
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 13430.56% in 2024, then plummeted by 6899.49% in 2025.
  • Generation Bio's Operating Expenses (Quarter) stood at $34.7 million in 2022, then grew by 19.06% to $41.3 million in 2023, then crashed by 32.8% to $27.8 million in 2024, then plummeted by 70.08% to $8.3 million in 2025.
  • Its Operating Expenses was $8.3 million in Q3 2025, compared to $23.7 million in Q2 2025 and $25.3 million in Q1 2025.